TMR research for over a year of questioning as high up to the world stage of briefings from WHO/PAHO/CARPHA, about the message to be given to COVID-19, its prevention by building immunity, and treatment that can mitigate the sufferings the virus brings; to the alternative to the suspicious and far from full protection from the experimental vaccines; brought us to this video: Vitamin D, Ivermectin, “Vaccines” https://www.bitchute.com/video/5UHDpnt6ZYrp/ – following our several Facebook posts at –https://www.facebook.com/themontserratreporter.
Dr. Ryan Cole is the CEO and Medical Director of Cole Diagnostics, one of the largest independent labs in the State of Idaho. Dr. Cole is a Mayo Clinic-trained Board Certified Pathologist.
This summary provides:
<<The current CDC and NIH recommendation: “Go home and isolate; if you can’t breathe or your lips turn blue, then go to the hospital” (this amounts to apathy, not treatment, as physicians are trained to treat people at the first instance of a disease/pathogen).
The earlier the treatment, the more complications that can be avoided over time (simple common sense).
If there is a treatment extant for a disease, then the federal government cannot approve a vaccine [for Emergency Use Authorisation by law . . . .
Six months ago, the World Health Organization said to “stop using Remdisivir because it doesn’t add survivability to any patients” (the drug only works during the first 2-3 days of infection).
Yet, many US hospitals still administer the drug at $3,000 per dose long after initial infection when the virus has already massively replicated.
Convalescent plasma also only works during the first 2-3 days when the virus is replicating (only obtained in the hospital when the treatment is no longer effective).
Monoclonal antibodies also only work during the first couple of days with the disease.
Administering steroids at the right point in the disease (during an inflammatory state) does add survival benefit.
Ivermectin (an anti-parasitic given to horses and dogs) is an effective prevention and treatment therapy.
Although an anti-parasitic, Ivermectin also is a phenomenal anti-viral prophylaxis and can be used for early treatment, immune modifier treatment during hospitalization, and post-COVID “long hauler” treatment.
Ivermectin is safe, effective, and INEXPENSIVE, having been taken by 4 billion people since the 1980s (it is on the world’s most essential drugs list!).
In Petri dish studies conducted, in August 2020, Ivermectin was found to have killed 99% of the virus, but the NIH recommended against its use.
Ivermectin has been given in the past to humans at 30-40 times the recommended dosage with no adverse effect (only two humans have ever been determined to have died after using the drug, and they had a rare immunodeficiency disease).
A few Ivermectin studies are finally being conducted independently in the US in Texas, Florida, and Wisconsin hospitals (results: they have decreased their COVID death rates by 70-90%!).
In Houston, one hospital was using it; now, all hospitals in Houston administer the drug.
It is an approved medicine, but it is off-label (approved for other uses) because the FDA has not approved its use to treat the virus because studies haven’t been completed on Americans – the FDA doesn’t use foreign studies to approve drugs).
However, Pfizer received FDA approval for its experimental vaccine based on tests on foreign subjects, not Americans (!).
In meta-analysis of 15,000 patients, Ivermectin – if added to the treatment plan, no matter what that plan is – reduces the death rate by at least 75% (up to 86% if given early) . . .
A full course of Ivermectin treat costs under $30.
Fully 100% of the world’s Ivermectin trials have shown benefits (details provided in the video presentation):
Decreases disease acquisition by 88-100%.
Decreases viral replication and shedding time by half.
Decreases disease course and severity by 80-90%.
Decreases disease death rate by 75% and up to 86% if administered early in treatment.
Ivermectin is the only medicine that has shown benefit in 100% of world trials conducted>>
